<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03558009</url>
  </required_header>
  <id_info>
    <org_study_id>EHA 01-2018</org_study_id>
    <nct_id>NCT03558009</nct_id>
  </id_info>
  <brief_title>Epidemiological Analysis for Hereditary Angioedema Disease</brief_title>
  <acronym>EHA</acronym>
  <official_title>Epidemiological Analysis for Hereditary Angioedema Disease: An International, Multicenter, Epidemiological Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CENTOGENE GmbH Rostock</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CENTOGENE GmbH Rostock</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An international, multicenter, epidemiological, observational study investigating the&#xD;
      prevalence of Hereditary Angioedema (HAE) disease among participants with recurrent episodes&#xD;
      of abdominal pain of no obvious etiology.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hereditary Angioedema (HAE) is a rare autosomal dominant disorder characterized most commonly&#xD;
      by deficient (type 1) or nonfunctional (type 2) C1 inhibitor protein (encoded by SERPING1&#xD;
      gene). The disorder is associated with episodes of angioedema of the face, larynx, lips,&#xD;
      abdomen, and extremities. The angioedema is caused by the activation of the kallikrein-kinin&#xD;
      system that leads to the release of vasoactive peptides, followed by edema, which in severe&#xD;
      cases can be life threatening.&#xD;
&#xD;
      Gastrointestinal involvement occurs in 93% of patients with HAE and may be the only&#xD;
      manifestation of the disease. However, individuals with gastrointestinal symptoms are rarely&#xD;
      considered for HAE and the disease can be misdiagnosed for several years.&#xD;
&#xD;
      EHA study focuses on the gastrointestinal complications of HAE as a potential area of&#xD;
      misdiagnosis leading to surgical morbidity. Aim of the study is to investigate the prevalence&#xD;
      of HAE among participants experiencing recurrent abdominal pain attacks with no clear&#xD;
      etiology. The HAE-positive samples in the study will be further analyzed biochemically to&#xD;
      identify disease-specific biomarker that may support the development of new diagnostic tools&#xD;
      for HAE disease.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Epidemiological analysis of prevalence of the HAE in participants with previous episodes of abdominal pain of no obvious etiology.</measure>
    <time_frame>4 years</time_frame>
    <description>Dry Blood Spot (DBS)-based biochemical measurements of C4 complement and the protease C1 inhibitor levels will be analyzed via liquid chromatography multiple reaction. The pathological biochemical results will be genetically validated via combination of the Next-Generation Sequencing (the mutation will be confirmed by Sanger sequencing) and Multiplex ligation-dependent probe amplification of SERPING1.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Establishment of a biomarker in HAE-positive cohort</measure>
    <time_frame>4 years</time_frame>
    <description>HAE-positive samples will be analyzed for the identification of potential biomarkers (based on MS/MS-Tandem spectroscopy) and compared with the merged control samples in order establish a HAE specific biomarker.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Abdominal Pain</condition>
  <condition>Functional Abdominal Pain</condition>
  <arm_group>
    <arm_group_label>Participants with abdominal pain attacks</arm_group_label>
    <description>Participants experiencing recurrent abdominal pain attacks without a clear etiolgy aged between 2-60 years</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample applied on the Dry Blood Spot (DBS) Filtercard (Centocard®)&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants with previous episodes of abdominal pain attacks of no obvious etiology&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        INCLUSION CRITERIA&#xD;
&#xD;
          -  Informed consent will be obtained from the participant or the parent or legal guardian&#xD;
&#xD;
          -  Participants with previous episodes of abdominal pain of no obvious etiology&#xD;
&#xD;
          -  Participants aged between 2 to 60 years old&#xD;
&#xD;
        EXCLUSION CRITERIA&#xD;
&#xD;
          -  Previous diagnosis of HAE&#xD;
&#xD;
          -  Inability to provide informed consent&#xD;
&#xD;
          -  The etiology of abdominal pain attacks is determined&#xD;
&#xD;
          -  Participants that are younger than 2 years old or older than 60 years old&#xD;
&#xD;
          -  Previous enrolled in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Bauer, MD</last_name>
    <role>Study Chair</role>
    <affiliation>CENTOGENE GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Selen Zülbahar, PhD</last_name>
    <phone>+49 (0)38180113341</phone>
    <email>Selen.Zuelbahar@centogene.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Praxis und Tagesklinik Prof. Dr. med. Jens Papke</name>
      <address>
        <city>Neustadt</city>
        <state>Sachsen</state>
        <zip>01844</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jens Papke, MD</last_name>
      <phone>+49 (0)359658530</phone>
      <email>mail@drpapke.de</email>
    </contact>
    <investigator>
      <last_name>Jens Papke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Düsseldorf, Klinik für Allgemein-, Viszeral- und Kinderchirurgie</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfram T. Knoefel, MD</last_name>
      <phone>+49 (0)22181173501</phone>
      <email>knoefel@uni-duesseldorf.de</email>
    </contact>
    <investigator>
      <last_name>Wolfram T. Knoefel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dr. med. Engelhard | Dr. med. Wihl, Internistische Gemeinschaftspraxis</name>
      <address>
        <city>Frankenberg</city>
        <zip>35066</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralf Engelhard, MD</last_name>
      <phone>+49 64516036</phone>
      <email>engelhard-frankenberg@t-online.de</email>
    </contact>
    <investigator>
      <last_name>Ralf Engelhard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Greifswald Körperschaft des öffentlichen Rechts</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali A. Aghdassi, MD</last_name>
      <phone>+49 3834867230</phone>
      <email>ali.aghdassi@med.uni-greifswald.de</email>
    </contact>
    <investigator>
      <last_name>Ali A. Aghdassi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Kassel GmbH</name>
      <address>
        <city>Kassel</city>
        <zip>34125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dirk Nielsen, MD</last_name>
      <phone>+49 (0)56120192883</phone>
      <email>dirk.nielsen@klinikum-kassel.de</email>
    </contact>
    <investigator>
      <last_name>Dirk Nielsen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Leipzig AöR</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Albrecht Hoffmeister, MD</last_name>
      <phone>+49 (0)3419712226</phone>
      <email>albrecht.hoffmeister@medizin.uni-leipzig.de</email>
    </contact>
    <investigator>
      <last_name>Albrecht Hoffmeister, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kinder- und Jugendklinik, Universitätsmedizin Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Däbritz, MD</last_name>
      <phone>+49 (0)3814947001</phone>
      <email>Jan.Daebritz@med.uni-rostock.de</email>
    </contact>
    <investigator>
      <last_name>Jan Däbritz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Antonio Cardarelli</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Del Mastro, MD</last_name>
      <phone>+39 (0)817472888</phone>
      <email>andreadelma84@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Andrea Del Mastro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hiroshima University Graduate School of Biomedical Sciences</name>
      <address>
        <city>Hiroshima</city>
        <zip>7348551</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michihiro Hide, MD</last_name>
      <phone>+81 (0)822575235</phone>
      <email>ed1h-w1de-road@hiroshima-u.ac.jp</email>
    </contact>
    <investigator>
      <last_name>Michihiro Hide, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastromed</name>
      <address>
        <city>Białystok</city>
        <zip>15-322</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacek Romatowski, MD</last_name>
      <phone>+48 (0)857336090</phone>
      <email>jromatowski@wp.pl</email>
    </contact>
    <investigator>
      <last_name>Jacek Romatowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Alfamedica Silesia North</name>
      <address>
        <city>Częstochowa</city>
        <zip>42218</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Żaneta Krawczyk-Antońska</last_name>
      <phone>+48 (0)343147107</phone>
      <email>zaneta.antonska@alfamedica.med.pl</email>
    </contact>
    <investigator>
      <last_name>Maciej Gonciarz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Specialized Medical Offices MeaMedica</name>
      <address>
        <city>Gdańsk</city>
        <zip>80-244</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krzysztof Kuziemski, Prof.</last_name>
      <phone>+48 (0)602185094</phone>
      <email>k.kuziemski@gumed.edu.pl</email>
    </contact>
    <investigator>
      <last_name>Krzysztof Kuziemski, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>WIP Warsaw IBD Point</name>
      <address>
        <city>Warsaw</city>
        <zip>00-728</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jarosław Kierkuś, MD</last_name>
      <phone>+48 (0)500111648</phone>
      <email>j.kierkus@med-net.pl</email>
    </contact>
    <investigator>
      <last_name>Jarosław Kierkuś, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Przychodnia Lekarska MediSpace</name>
      <address>
        <city>Warszawa</city>
        <zip>1044</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michał Wszoła, MD</last_name>
      <phone>+48 (0)501506071</phone>
      <email>ewa.wszola@medispace.pl</email>
    </contact>
    <investigator>
      <last_name>Michał Wszoła, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uniwersytecki Szpital Kliniczny</name>
      <address>
        <city>Wrocław</city>
        <zip>50-556</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elżbieta Poniewierka, MD</last_name>
      <phone>+48 (0)717332120</phone>
      <email>eponiewierka@usk.wroc.pl</email>
    </contact>
    <investigator>
      <last_name>Elżbieta Poniewierka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cdl &quot;Barska&quot;</name>
      <address>
        <city>Włocławek</city>
        <zip>87 - 800</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maciej Kowalski, MD</last_name>
      <phone>+48 (0)2334033</phone>
      <email>makabi@wp.pl</email>
    </contact>
    <investigator>
      <last_name>Maciej Kowalski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cukurova University Balcali Hospital</name>
      <address>
        <city>Adana</city>
        <zip>01330</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmet Sebe, MD</last_name>
      <phone>+90 (0)3223386060</phone>
      <email>asebe@cu.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Ahmet Sebe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bezmialem Vakif Üniversitesi</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Metin Basaranoglu, Prof.</last_name>
      <phone>+90 (0)2124531700</phone>
      <email>metin_basaranoglu@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Metin Basaranoglu, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ege University Faculty of Medicine</name>
      <address>
        <city>Izmir</city>
        <zip>35100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nalan G. Ünal, MD</last_name>
      <phone>+90 (0)2323905198</phone>
      <email>drnalanunal@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Nalan G. Ünal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dokuz Eylül University Research and Application Hospital</name>
      <address>
        <city>Izmir</city>
        <zip>35330</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Göksel Bengi, MD</last_name>
      <phone>+90 (0)2324123713</phone>
      <email>goksel.bengi@deu.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Göksel Bengi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aberdeen Royal Infirmary</name>
      <address>
        <city>Aberdeen</city>
        <zip>AB252ZN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University Hospital of Derby and Burton NHS Foundation Trust</name>
      <address>
        <city>Derby</city>
        <zip>DE22 3NE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Royal Infirmary of Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth University Hospital</name>
      <address>
        <city>Glasgow</city>
        <zip>G514TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Royal Alexandra Hospital</name>
      <address>
        <city>Glasgow</city>
        <zip>PA29PN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Crosshouse</name>
      <address>
        <city>Kilmarnock</city>
        <zip>KA20BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Leicester (UHL)</name>
      <address>
        <city>Leicester</city>
        <zip>LE1 5WW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>The Royal London Hospital</name>
      <address>
        <city>London</city>
        <zip>E1 1BB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>St Thomas Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>St George's University Hospital London</name>
      <address>
        <city>London</city>
        <zip>SW17 0RE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Imperial College Healthcare NHS Trust</name>
      <address>
        <city>London</city>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Manchester Royal Infirmary</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Milton Keynes Hospital</name>
      <address>
        <city>Milton Keynes</city>
        <zip>MK6 5LD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Poland</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://www.centogene.com/clinical-studies/hereditary-angioedema-disease.html</url>
    <description>Related info.</description>
  </link>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 5, 2018</study_first_submitted>
  <study_first_submitted_qc>June 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2018</study_first_posted>
  <last_update_submitted>April 12, 2021</last_update_submitted>
  <last_update_submitted_qc>April 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hereditary Angioedema</keyword>
  <keyword>DBS-based biochemical and genetic assay for HAE type I/II</keyword>
  <keyword>Biomarker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angioedema</mesh_term>
    <mesh_term>Angioedemas, Hereditary</mesh_term>
    <mesh_term>Abdominal Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

